The Lunsekimig project team is part of Early Development in the Inflammation & Immunology Therapeutic Area at Sanofi. Our team is developing a novel pentavalent, bispecific Nanobody for the treatment of asthma and other “Type 2” inflammatory diseases. Lunsekimig is being evaluated across multiple respiratory indications as well as atopic dermatitis. Join the engine of Sanofi’s mission — where deep immunoscience meets bold, AI-powered research. In R&D, you’ll drive breakthroughs that could turn the impossible into possible for millions. About Sanofi: We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives. The primary purpose of this Lead Clinical Scientist position is to assist/support the Lunsekimig Clinical Lead in the strategic approach to medical/scientific contribution for clinical studies related to a respiratory indication, on activities pertaining to the Study Medical Manager responsibilities e.g.: managing or contributing to the operational activities from clinical trial set-up to clinical study report in compliance with quality and regulatory processes.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree
Number of Employees
11-50 employees